To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF
Status:
Not yet recruiting
Trial end date:
2025-02-03
Target enrollment:
Participant gender:
Summary
A participant- and investigator-blinded, randomized, placebo-controlled, multicenter,
platform study to investigate efficacy, safety, and tolerability of various single treatments
in participants with idiopathic pulmonary fibrosis